Background Placing the left ventricular (LV) lead in a viable segment with the latest
mechanical activation (vSOLA) may be associated with optimal cardiac resynchronization …

Cardiac resynchronization therapy (CRT) is now a well-recognized therapeutic option for
patients with end-stage heart failure. However, not all patients respond to CRT, and …

Background: Cardiac resynchronization therapy (CRT) is an established treatment in
patients with end-stage heart failure and wide QRS complex. However, about 30% of …

The significance of left ventricular (LV) dyssynchrony for the prediction of response to
cardiac resynchronization therapy (CRT) has been demonstrated. Parameters reflecting LV …

Clinical interest continues in identifying heart failure patients who will improve with cardiac
resynchronization therapy (CRT). Since the advent of applying phase analysis to measure …

Background Mechanical left ventricular dyssynchrony (MLVD) might contribute in the
therapeutic decision-making in patients with heart failure (HF) prior to cardiac …

Background The purpose of this study was to establish the repeatability of left-ventricular
(LV) dyssynchrony and function parameters measured from serial gated myocardial …

Background The outcome of patients with severe ischaemic left ventricular (LV) dysfunction
is determined by the extent of myocardial viability and the presence of LV dyssynchrony. We …

Background Cardiac resynchronization therapy (CRT) patients with different
pathophysiology may influence mechanical dyssynchrony and get different ventricular …

Cardiac resynchronization therapy (CRT) has shown benefits in patients with end-stage
heart failure, depressed left ventricular (LV) ejection fraction (≤ 35%), and prolonged QRS …